Estrogen Vaginal Rings
Last Updated: May 15, 2015
Products Affected - Description
There are no products affected.
Reason for the Shortage
Pfizer had Estring on shortage due to manufacturing delays.
Femring (estradiol acetate) vaginal ring, Actavis
12.4 mg, 0.05 mg/24 hour, 1 count (NDC 00430-6201-40)
24.8 mg, 0.1 mg/24 hour, 1 count (NDC 00430-6202-40)
2 mg, 0.0075 mg/24 hour, 1 count (NDC 00013-2150-36)
Estimated Resupply Dates
Pfizer has Estring available and Actavis has Femring available.
- Esterified Estrogens and Methyltestosterone Tablets — Resolved
- Estradiol Tablets — Resolved
- Estradiol Valerate Injection — Current
- Synthetic Conjugated Estrogen — Current
May 15, April 29, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.